저자: Kevin · 외국인
요약 보기
코로나 치료제 렘데시비르(Gilead)에 대한 임상 관련 소식(일화적 증거, 체외 실험, 원숭이 연구, 생산 확대)을 정리하며 길리어드 주가 상승 가능성을 언급. 옵션 투자 시나리오를 예로 들면서 투자 권유가 아니라고 강조. 구독·부동산 강의 홍보 포함.
다듬은 글
hey everyone Kevin here but now you've probably heard that there's a potential drug treating the illness that the corona virus causes which is really cool we heard of this anecdotal evidence on Thursday which is basically just a fancy way of saying people were talking about oh crap this might actually be working this is good and sure enough what happened well that's snuck in after hours shot up 16 to 18 percent and value in the next day almost the entire stock market was up somewhere between 8 to 10 percent depending on which it's not you looked at well I can't help but asking does that mean there is a potential opportunity to invest in the drug maker who makes this drug and potentially double or triple our money you can't fault me for asking and so in this video I'm going to go through with you all of my research that I've put together over the last of three days all of the various different studies I'm just gonna give you the key points the key findings I'm gonna show you how you might either make double or triple your money or you'll just go bankrupt so let's talk about it starting right now first things first it's always helpful to understand there's a difference between a cure or a treatment something that solves a problem once you have it and a vaccine which is something that prevents you from getting something in the first place a vaccine is something that generally everybody gets which means there's this never-ending pool of people who need the drug which is a never-ending source of revenue until somebody makes a generic for that company on the flip side a cure is kind of like coming up with an anti-venom for snake bites or spider bites your only potential customers are people who are getting bit by black widows and toxic spiders and snakes so in other words long term a cure or a treatment is probably going to be a lot less profitable than a long term vaccine for what we're against well right now we are talking about a cure or a treatment and the drug is called REM des Vere and whether we get a cure or a vaccine when we get one of these with at least some degree of certainty the odds are the stock market rally with enthusiasm so that we can finally officially open up the economy and not have to worry about second waves or third waves putting us back into quarantine and social distancing but for now we're just going to focus on REM des vir and we're going to try to figure out if REM des vir and that specific potential cure or treatment get make it double or triple our money let's start with the recap from Thursday on Thursday we heard anecdotal evidence basically just a recording of some doctors talking to each other which the stat news publication spilled the beans on there I believe a subsidiary or division or were created by the Boston Globe anyway they spilled the beans and said hey we heard some doctors saying that 125 people were severely sick with kovat 19 and we heard that 113 of them are good and out of the whole batch two of them died and that most people were getting cured within six days by using this REM des aveer drug that sounds really good but it's also possibly a game of telephone that is just because somebody says well this looks really good doesn't actually mean we have something tangible that should merit us being able to double our triple our money so this is where we have to look towards other studies like the one that came out a day later but before I talk about the study that came out the day after we heard about this anecdotal evidence I want to talk about a little bit of background back on February 4th of 2020 we learned that REM des of EUR works really really well in vitro against the corona virus which basically means that REM des aveer works really well against the virus in a test tube it's kind of like when you put the lime in the coconut and you shake it all up all of a sudden the virus is dead that's good that's what we knew about 60 days ago then on April 13th from an article published in the Journal of biological chemistry we learned that REM DES of year is a direct acting antiviral that inhibits the RNA dependent blah-blah-blah-blah-blah basically the drug appears to work against the things that make the work aka another good indicator this was all around the same time that doctors in Sweden found wow this REM des Vere stuff actually really does work well against the coronavirus especially in test tubes and we're gonna start trying it on people this isn't even to mention that at the beginning of March as the outbreak was really starting to spread to the United States multiple executives at Gilead were buying shares for Gilead stock and then just yesterday Reuters announced that clinical trials for REM des Vere are being bumped from 2400 potential patients to 6000 patients by the company Gilead which yesterday is also the day The Economist's thought it was quite interesting that Gilead is massively ramping up production of REM des aveer in fact here's a quote from Gilead directly as of late March using the active ingredient we already had in our inventory we have increased our supply of to more than 30,000 patient courses of REM des aver on hand assuming a 10-day course as new raw materials arrive over the next few weeks from our manufacturing partners around the world blah blah blah blah blah every day we're improving the process blah blah blah blah blah our goal is to produce a total of more than a hundred forty thousand treatment courses by the end of May more than 500,000 treatment courses by the end of October and more than 1 million treatment courses by December 2020 and several million treatment courses in 2021 if required in other words as Fed Chairman Jerome Powell is cranking out money to his choice companies and Airlines and his other favorite companies we are over here watching Gilead in the background going we're cranking out cures we're cranking out more REM desi beer all of this so far seems to corroborate what we're hearing as anecdotal evidence from the trials going on at the University of Chicago Hospital now before I talk about this new and most recent study that was published let me just make this a very very clear we have professors and instructors from Harvard and we have people in news publications across the world including the New York Times and The Economist's all saying the same thing don't get your hopes up nobody's drinking champagne to this this is just anecdotal stuff we heard at the hospital the stuff that we hear at the hospital is good sounding but without controlled studies and solid scientific data this is no more than hearsay and we've seen many times before that things like this have been heard and then the drug ends up failing just totally true totally fair absolutely accurate well then comes a media advisory published in the National Institutes of Health called antiviral REM des aveer prevents disease progression in monkeys with kovat 19 not test tubes not rats monkeys early treatment with the experimental antiviral drug REM des Vere significantly reduced clinical disease and damage to the lungs of certain monkeys technical term here infected with the corona virus that causes Kovan 19 they do mention this asterisk the findings are not peer-reviewed and should not be considered clinical advice but are being shared to assist the public health response to kovat 19 now the study of monkeys involved just 12 monkeys 6 were treated and 6 were not and after 12 hours of the initial treatment they found that the six that were treated were in significantly better health than the untreated group they reported that one of the six treated animals showed minor breathing difficulty whereas all six of the untreated animals showed rapid and difficult breathing the amount of the virus found in the lungs was significantly lower in the treatment group compared with the untreated group and the corona virus caused the less damage to the lungs and treated animals than in untreated animals so when I first broke this two days ago I said look I don't like farm stocks that is I don't like any kind of pharmaceutical stuff I don't get it I don't fully understand it I I don't know much about this stuff I'm trying to report to you one I've been reading and what I've been taking in but now I'm going to go into spec mode here and say what is it going to take for us to double our money I just wanna make this very clear because I do not want to be sued this is not financial advice do not make this move that I'm about to tell you and then sue me if you lose money if you lose money it's your fault if you make a lot of money well in that case you may as well come back and buy my awesome real estate investing course so you can really learn how to make a buck by investing in real estate a link down below with the coupon code right next to your link for getting a quote for Life Insurance in under five minutes you could even sign up in under five minutes and of course getting get a really sick stock trading platform which you're going to need a very awesome stock trading platform to make this move happen actually probably any stock trading platform will do but let me explain how you might be able to trade Gilead based on this information I'm just gonna call it speculative here again don't want to get sued but how could we trade Gilead and double our money let's talk about that first it's helpful to know that the stock we're talking about here is Gilead G IL d is the ticker symbol and right now at rates for around eighty four dollars per share Gilead used to trade for as high as $120 per share following the Ebola outbreak which guess what REM des Vere was actually researched and manufactured to treat Ebola but it failed it failed to treat Ebola so even though the stock shot up from the high 60s to $120 a share the stock quickly retreated back to the 60s and 70s after REM des aveer failed to treat Ebola but this time is different see this time the drug is already manufactured and this time we have rumors that it works good sign right I mean obviously we have some studies as well but let's just talk about the stock for right now let's say that right now you had eighteen thousand nine hundred dollars and you were thinking you know what should I invest in GI LD or Gilead on the hopes that this REM des is going to work and it is going to be the cure for kovat 19 well if you invest in the stock at $84 and let's say the stock now goes up to 100 dollars in value well at eighteen thousand nine hundred dollars you would be able to buy two hundred twenty-five shares of Gilead which would mean if the stock went up to a hundred dollars you would make a grand total of three thousand six hundred dollars well that's not really doubling your money well fine let's say the stock went back to a hundred twenty dollars a share let's try it that way well then you would make eight thousand one hundred dollars also not quite doubling your money so let's now talk about doubling your money using options let's say I'm really bullish on this and I blow my entire eighteen thousand nine hundred dollars on twenty option contracts which will give me the right to buy two thousand shares of Gilead at eighty two dollars and fifty cents on June 19th now don't worry you don't actually have to buy two thousand shares because I know this is a lot of money right now we're just focused on that eighteen thousand nine hundred dollars because this option contract set that you're buying becomes tradable well here's the fun part right now Gilead is expecting results at least preliminary results on these trials at the end of April but with the contracts we're buying here we would have room until June 19th for this stock to go up to our target prices which is really everything above $92 right now it's around eighty three eighty four dollars and if that stock goes up by June nineteenth two ninety two dollars we will make nine hundred dollars in other words this is like our breakeven here okay this is this is the bare minimum we want is nine hundred dollars this is our rough breakeven as long as it's selling for around ninety two we don't lose any money if it's selling for less than ninety two we start losing money and if it sells for anything less than eighty two dollars and fifty cents well then we lost all of our eighteen thousand nine hundred dollars and we basically just yolo'd it and wrote it off as a chapter in our life of making a stupid decision following some dudes advice on YouTube see now you can't say that I did not tell you not to do this but if you're crazy enough to continue and you decide you know what I might be crazy enough to actually make this investment fine if the stock by June 19th shoots up to a hundred and one dollars and forty cents guess what will happen you will approximately have doubled your money and obviously check my math I'm a dude using a whiteboard so check my math but if the stock goes up from a strike price of 82 52 101 4 and at the current option price is for this date you'll have roughly doubled your money that's pretty cool but what if it goes back to its ebola peak back in the day where it was at $120 per share well in that case you might end up making a profit from this bet of investing $18,900 make an additional profit on top of the eighteen thousand nine hundred dollars that you made well in addition to getting your eighteen thousand nine hundred dollars back you would make a profit of fifty-six thousand one hundred dollars which means you will almost have tripled your money or like I said the Cure will flop and you'll lose all of your $18,900 the choice is yours the good news is Gilead does have a very nice current cash position they have at the end of 2019 over twenty five billion dollars in cash apparently this drug only costs about a dollar per day to manufacture and Gilead has about 25 billion dollars in debt so Gilead could basically take all their cash and pay off every dime of debt they have that's pretty cool but what's not cool is Gilead revenue has basically been declining ever since the Ebola outbreak and their net income has been going on a slippery slope straight down so this might be make it or break it for their current valuation so obviously and as usual here is a spec stock for you and if you're looking for a guarantee you're not going to find it here but where you can get a guarantee is that you can get some amazing knowledge in my programs on realist investing down of the links below where I teach you how to actually buy deals below market value not just buy any crap or any apartment building I actually learn how to buy real estate the low market value so that the day you close escrow you know you're up money of course those links in that coupon code sitting right over there next to the place where you can of course your life insurance quote we'll see y'all soon thanks so much
Comments 0